A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF VS 6063 IN SUBJECTS WITH MALIGNANT PLEURAL MESOTHELIOMA
- Registry ID
- VS-6063-202
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- VERASTEM INCORPORATED
- Start date
- 2013-07-01
- Last update
- 2013-08-01
Conditions
- MALIGNANT PLEURAL MESOTHELIOMA
View on source registry